In the BioHarmony Drug Report Database
Beclomethasone
Beclovent, Beconase, Qnasl, Qvar, Vancenase, Vanceril (beclomethasone dipropionate) is a small molecule pharmaceutical. Beclomethasone dipropionate was first approved as Beclovent on 1982-01-01. It is used to treat allergic rhinitis perennial and inflammation in the USA. It is known to target adhesion G protein-coupled receptor G3. Beconase aq’s patents are valid until 2039-01-25 (FDA).
Trade Name
|
Beclovent, Beconase, Qnasl, Qvar, Vancenase, Vanceril |
|---|---|
Common Name
|
beclomethasone dipropionate |
ChEMBL ID
|
CHEMBL1200500 |
Indication
|
allergic rhinitis perennial, inflammation |
Drug Class
|
Image (chem structure or protein)